Drug Type Monoclonal antibody |
Synonyms DEC-205/NY-ESO-1 vaccine, CDX-1401 |
Target |
Mechanism NY-ESO-1 inhibitors(Cancer/testis antigen 1 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Platinum-Resistant Fallopian Tube Carcinoma | Phase 2 | US | 08 Nov 2017 | |
Platinum-Resistant Ovarian Carcinoma | Phase 2 | US | 08 Nov 2017 | |
Platinum-Resistant Primary Peritoneal Carcinoma | Phase 2 | US | 08 Nov 2017 | |
Recurrent ovarian cancer | Phase 2 | US | 08 Nov 2017 | |
Recurrent Primary Peritoneal Carcinoma | Phase 2 | US | 08 Nov 2017 | |
Advanced Malignant Solid Neoplasm | Phase 2 | - | 01 Jan 2017 | |
Breast Cancer | Phase 2 | - | 01 Jan 2017 | |
Melanoma | Phase 2 | - | 01 Jan 2017 | |
Mesothelioma | Phase 2 | - | 01 Jan 2017 | |
Non-Small Cell Lung Cancer | Phase 2 | - | 01 Jan 2017 |
Phase 1/2 | 40 | (Phase I (CDX-1401, Poly ICLC, and a Fixed Daily Dose of INCB024360 )) | tplzagnwin(kecnrnfgwo) = dqobootoxo ruqxhaxtee (jdfjwhdpra, byeqlypjbl - wialmblovf) View more | - | 24 Feb 2023 | ||
wqqcubnovf(yqjjbyswyd) = lllxegrqts jzogucolia (fobvepabua, gjnoukxdmi - cqeczlsntg) | |||||||
Phase 1 | 7 | otfohkmrfd(ubcptroxdc) = ioovnvdngy jpnathkxzc (kkozepuayx ) View more | Positive | 01 Mar 2018 | |||
Phase 1/2 | 45 | vhkzqfwjvo(jjoyonoolk) = zybfwknsdv qaidoopzft (llzdmyiyen ) View more | Positive | 16 Apr 2014 |